CHCHD6
MICOS complex subunit MIC25
Also known as: CHCM1, MGC13016, Mic25, MIC25_HUMAN, MICOS25, PPP1R23
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRQ6
- Gene
- CHCHD6
- Ensembl
- ENSG00000159685
- Chromosome
- 3
- Canonical length
- 235 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
OverviewNCBI Gene
Involved in DNA damage response and cristae formation. Located in cytosol and mitochondrial inner membrane. Part of MICOS complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q9BRQ6|CHCHD6
1 MGSTESSEGR RVSFGVDEEE RVRVLQGVRL SENVVNRMKE PSSPPPAPTS STFGLQDGNL
61 RAPHKESTLP RSGSSGGQQP SGMKEGVKRY EQEHAAIQDK LFQVAKRERE AATKHSKASL
121 PTGEGSISHE EQKSVRLARE LESREAELRR RDTFYKEQLE RIERKNAEMY KLSSEQFHEA
181 ASKMESTIKP RRVEPVCSGL QAQILHCYRD RPHEVLLCSD LVKAYQRCVS AAHKGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHCHD6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 62 nTPM
- cerebral cortex: 55 nTPM
- testis: 51 nTPM
- amygdala: 46 nTPM
- basal ganglia: 41 nTPM
- hypothalamus: 34 nTPM
Single-cell type
- melanocytes: 455 nCPM
- hofbauer cells: 388 nCPM
- late primary spermatocytes: 256 nCPM
- oocytes: 226 nCPM
- respiratory ciliated cells: 165 nCPM
- late spermatids: 164 nCPM
Immune cell
- naive B-cell: 12 nTPM
- naive CD8 T-cell: 11 nTPM
- memory CD4 T-cell: 10 nTPM
- T-reg: 10 nTPM
- naive CD4 T-cell: 9.4 nTPM
- MAIT T-cell: 8.8 nTPM
Brain region
- hippocampal formation: 52 nTPM
- cerebral cortex: 45 nTPM
- basal ganglia: 30 nTPM
- hypothalamus: 26 nTPM
- white matter: 24 nTPM
- midbrain: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.62
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MICOS complex subunit MIC19/MIC25
- MICOS complex subunit MIC19/MIC25
- MICOS complex subunit MIC25
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHCHD6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHCHD6 as an antibody target. Whether an autoantibody or antibody against CHCHD6 could matter depends on whether native CHCHD6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHCHD6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHCHD6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...